Last Posted: Sep 10, 2020
- Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.
Raal Frederick J et al. Arteriosclerosis, thrombosis, and vascular biology 2020 Sep ATVBAHA120315040 - High prevalence of increased sitosterol levels in hypercholesterolemic children suggest underestimation of sitosterolemia incidence.
Lee Joon Hee et al. PloS one 2020 15(8) e0238079 - Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia.
Vuorio Alpo et al. Journal of clinical lipidology 2020 Jun - Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
Kose Engin et al. Journal of pediatric endocrinology & metabolism : JPEM 2020 Aug - Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study.
Gulizia Michele Massimo et al. Atherosclerosis 2020 Jul 30832-38 - Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
AC Fahed et al, Nature Communications, August 20, 2020 - Bypassing the LDL Receptor in Familial Hypercholesterolemia.
Kersten Sander et al. The New England journal of medicine 2020 Aug (8) 775-776 - Evinacumab for Homozygous Familial Hypercholesterolemia.
Raal Frederick J et al. The New England journal of medicine 2020 Aug (8) 711-720 - Identification of Undetected Monogenic Cardiovascular Disorders.
Abdulrahim Jawan W et al. Journal of the American College of Cardiology 2020 Aug 76(7) 797-808 - Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies.
Pasta Andrea et al. Atherosclerosis 2020 Jul 3086-14
.png)
No hay comentarios:
Publicar un comentario